Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors
暂无分享,去创建一个
E. Kieff | G. Lenoir | K. Josefsen | R. Yalamanchili | M. Birkenbach | K. Josefsen | Ram Yalamanchili
[1] Albrecht,et al. Primary structure of the herpesvirus saimiri genome , 1992, Journal of virology.
[2] Richard G. W. Anderson,et al. Annexin VI is required for budding of clathrin-coated pits , 1992, Cell.
[3] P. C. White,et al. Genetic analysis of the human type-1 angiotensin II receptor. , 1992, Molecular endocrinology.
[4] R. Desrosiers,et al. Stable growth transformation of human T lymphocytes by herpesvirus saimiri. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[5] R. Honess,et al. Herpesvirus saimiri encodes homologues of G protein-coupled receptors and cyclins , 1992, Nature.
[6] S. Seino,et al. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[7] R. Duman,et al. Sequence and expression of a neuropeptide Y receptor cDNA. , 1991, Molecular pharmacology.
[8] M. Kozak. Structural features in eukaryotic mRNAs that modulate the initiation of translation. , 1991, The Journal of biological chemistry.
[9] P. Murphy,et al. Cloning of complementary DNA encoding a functional human interleukin-8 receptor. , 1991, Science.
[10] W I Wood,et al. Structure and functional expression of a human interleukin-8 receptor. , 1991, Science.
[11] E. Rozengurt,et al. Protein kinase C activation potently down‐regulates the expression of its major substrate, 80K, in Swiss 3T3 cells. , 1991, The EMBO journal.
[12] R. Frade,et al. Intracellular interaction of EBV/C3d receptor (CR2) with p68, a calcium-binding protein present in normal but not in transformed B lymphocytes. , 1991, Journal of immunology.
[13] D. Harlan,et al. The human myristoylated alanine-rich C kinase substrate (MARCKS) gene (MACS). Analysis of its gene product, promoter, and chromosomal localization. , 1991, The Journal of biological chemistry.
[14] E. Kieff,et al. Induction of bcl-2 expression by epstein-barr virus latent membrane protein 1 protects infected B cells from programmed cell death , 1991, Cell.
[15] M. Baggiolini,et al. Neutrophil-activating peptide 2 and gro/melanoma growth-stimulatory activity interact with neutrophil-activating peptide 1/interleukin 8 receptors on human neutrophils. , 1991, The Journal of biological chemistry.
[16] E. Goetzl,et al. Cloning and expression of the human vasoactive intestinal peptide receptor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[17] A. Nairn,et al. Regulation by phosphorylation of reversible association of a myristoylated protein kinase C substrate with the plasma membrane , 1991, Nature.
[18] U. Nater,et al. Epstein-Barr virus. , 1991, The Journal of family practice.
[19] S. Fleischer,et al. Annexin VI is associated with calcium‐sequestering organelles , 1991, Journal of cellular biochemistry.
[20] E. Kieff,et al. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation , 1991, Journal of virology.
[21] E. Kieff,et al. Early events in Epstein-Barr virus infection of human B lymphocytes. , 1991, Virology.
[22] V. Wheaton,et al. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation , 1991, Cell.
[23] P. Blackshear,et al. Phosphorylation-dependent binding of a synthetic MARCKS peptide to calmodulin. , 1991, The Journal of biological chemistry.
[24] E. Puré,et al. High levels of CD44 expression distinguish virgin from antigen-primed B cells , 1991, The Journal of experimental medicine.
[25] P C Sternweis,et al. Regulation of polyphosphoinositide-specific phospholipase C activity by purified Gq. , 1991, Science.
[26] D. Tuveson,et al. Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19 , 1991, The Journal of experimental medicine.
[27] A. Strosberg. Structure/function relationship of proteins belonging to the family of receptors coupled to GTP-binding proteins. , 1991, European journal of biochemistry.
[28] L. Kjellén,et al. Proteoglycans: structures and interactions. , 1991, Annual review of biochemistry.
[29] K. Matsushima,et al. Properties of the novel proinflammatory supergene "intercrine" cytokine family. , 1991, Annual review of immunology.
[30] J. Thorner,et al. Model systems for the study of seven-transmembrane-segment receptors. , 1991, Annual review of biochemistry.
[31] S. O. Kolset,et al. Proteoglycans in haemopoietic cells. , 1990, Biochimica et biophysica acta.
[32] R. Fåhraeus,et al. Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[33] A. Nairn,et al. Activation of protein kinase C results in the displacement of its myristoylated, alanine-rich substrate from punctate structures in macrophage filopodia , 1990, The Journal of experimental medicine.
[34] E. Myers,et al. Basic local alignment search tool. , 1990, Journal of molecular biology.
[35] E. Kieff,et al. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1 , 1990, Journal of virology.
[36] M. Rowe,et al. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. , 1990, The Journal of general virology.
[37] I. Stamenkovic,et al. CD44 is the principal cell surface receptor for hyaluronate , 1990, Cell.
[38] J. Knutson. The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for B-cell immortalization , 1990, Journal of virology.
[39] E. Kieff,et al. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23 , 1990, Journal of virology.
[40] B. Barrell,et al. Human cytomegalovirus encodes three G protein-coupled receptor homologues , 1990, Nature.
[41] J. Banchereau,et al. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23 , 1990, Journal of virology.
[42] J. Graff,et al. Phosphorylation-regulated calmodulin binding to a prominent cellular substrate for protein kinase C. , 1989, The Journal of biological chemistry.
[43] P. Kenton,et al. The phosphorylation of p68, a calcium-binding protein associated with the human syncytiotrophoblast submembranous cytoskeleton, is modulated by growth factors, activators of protein kinase C and cyclic AMP. , 1989, Biochimica et biophysica acta.
[44] J. Monroe,et al. Involvement of a specific guanine nucleotide binding protein in receptor immunoglobulin stimulated inositol phospholipid hydrolysis. , 1989, Biochimica et biophysica acta.
[45] E. Kieff,et al. Epstein-Barr virus latent infection membrane protein increases vimentin expression in human B-cell lines , 1989, Journal of Virology.
[46] W. Paul,et al. A major myristylated substrate of protein kinase C and protein kinase C itself are differentially regulated during murine B- and T-lymphocyte development and activation , 1989, Molecular and cellular biology.
[47] P. Hargrave,et al. Three cytoplasmic loops of rhodopsin interact with transducin. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[48] T. Jessell,et al. Ectopic expression of the serotonin 1c receptor and the triggering of malignant transformation. , 1989, Science.
[49] G. Guy,et al. Epstein‐barr virus and a tumour‐promoting phorbol ester use similar mechanisms in the stimulation of human b‐cell proliferation , 1989, International journal of cancer.
[50] S. Orrenius,et al. Glucocorticoids activate a suicide process in thymocytes through an elevation of cytosolic Ca2+ concentration. , 1989, Archives of biochemistry and biophysics.
[51] E. Kieff,et al. Epstein-Barr VirusLatentInfection MembraneProtein Increases Vimentin Expression inHumanB-Cell Lines , 1989 .
[52] D. Higgins,et al. See Blockindiscussions, Blockinstats, Blockinand Blockinauthor Blockinprofiles Blockinfor Blockinthis Blockinpublication Clustal: Blockina Blockinpackage Blockinfor Blockinperforming Multiple Blockinsequence Blockinalignment Blockinon Blockina Minicomputer Article Blockin Blockinin Blockin , 2022 .
[53] E. Kieff,et al. Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity , 1988, Journal of virology.
[54] M. Lipinski,et al. Isolation of a normal B cell subset with a Burkitt‐like phenotype and transformation in vitro with Epstein‐Barr virus , 1988, International journal of cancer.
[55] C. Strader,et al. Conserved aspartic acid residues 79 and 113 of the beta-adrenergic receptor have different roles in receptor function. , 1988, The Journal of biological chemistry.
[56] E. Kieff,et al. The truncated form of the Epstein-Barr virus latent-infection membrane protein expressed in virus replication does not transform rodent fibroblasts , 1988, Journal of virology.
[57] M. Harnett,et al. G protein coupling of antigen receptor-stimulated polyphosphoinositide hydrolysis in B cells. , 1988, Journal of immunology.
[58] V. Baichwal,et al. Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus. , 1988, Oncogene.
[59] L. Bourguignon,et al. Mouse T lymphoma cells contain a transmembrane glycoprotein (GP85) that binds ankyrin , 1988, The Journal of cell biology.
[60] M. Crumpton,et al. Primary structure of the human, membrane‐associated Ca2+‐binding protein p68 a novel member of a protein family. , 1988, The EMBO journal.
[61] T. Springer,et al. Epstein-Barr VirusLatent Infection MembraneProtein Alters the HumanB-Lymphocyte Phenotype: Deletion oftheAminoTerminus Abolishes Activity , 1988 .
[62] M. Gold,et al. Involvement of a guanine-nucleotide-binding component in membrane IgM-stimulated phosphoinositide breakdown. , 1987, Journal of immunology.
[63] J. Banchereau,et al. Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[64] M. Nahm,et al. Subpopulations of B lymphocytes in germinal centers. , 1987, Journal of immunology.
[65] L. Young,et al. Differences in B cell growth phenotype reflect novel patterns of Epstein‐Barr virus latent gene expression in Burkitt's lymphoma cells. , 1987, The EMBO journal.
[66] E. Kieff,et al. Epstein-barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis , 1987, Cell.
[67] M. Lipinski,et al. Identification of a subset of normal B cells with a Burkitt's lymphoma (BL)-like phenotype. , 1987, Journal of immunology.
[68] E. Kieff,et al. An Epstein-Barr virus transforming protein associates with vimentin in lymphocytes , 1987, Molecular and cellular biology.
[69] E. Kieff,et al. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[70] G. Klein,et al. Expression of B‐cell‐specific markers in different burkitt lymphoma subgroups , 1987, International journal of cancer.
[71] G. Lenoir,et al. EBV‐negative and ‐positive burkitt cell lines variably express receptors for B‐cell activation and differentiation , 1986, International journal of cancer.
[72] W. Paul,et al. Anti-immunoglobulin and phorbol ester induce phosphorylation of proteins associated with the plasma membrane and cytoskeleton in murine B lymphocytes. , 1986, The Journal of biological chemistry.
[73] T. Suzuki,et al. Identification of an early activation antigen (Bac-1) on human B cells. , 1986, Journal of immunology.
[74] M. Rowe,et al. Control of human B-lymphocyte replication. II. Transforming Epstein-Barr virus exploits three distinct viral signals to undermine three separate control points in B-cell growth. , 1986, Immunology.
[75] C. Rooney,et al. Epstein‐Barr virus status and tumour cell phenotype in sporadic Burkitt's lymphoma , 1986, International journal of cancer.
[76] S. Swendeman,et al. Biochemical analysis suggests distinct functional roles for the BLAST-1 and BLAST-2 antigens. , 1986, Journal of immunology.
[77] E. Kieff,et al. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells , 1985, Cell.
[78] R. Schooley,et al. BLAST-2 [EBVCS], an early cell surface marker of human B cell activation, is superinduced by Epstein Barr virus. , 1985, Journal of immunology.
[79] M. Epstein,et al. Distinctions between endemic and sporadic forms of epstein‐barr virus‐positive burkitt's lymphoma , 1985, International journal of cancer.
[80] A. Freedman,et al. Studies of in vitro activation and differentiation of human B lymphocytes. I. Phenotypic and functional characterization of the B cell population responding to anti-Ig antibody. , 1985, Journal of immunology.
[81] D. Fearon,et al. Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[82] G. Klein,et al. Phenotypic and cytogenetic characteristics of human B-lymphoid cell lines and their relevance for the etiology of Burkitt's lymphoma. , 1982, Advances in cancer research.
[83] L. Nadler,et al. Expression of cell surface markers after human B lymphocyte activation. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[84] G. Klein,et al. Cell-surface immunoglobulin and insulin receptor expression in an EBV-negative lymphoma cell line and its EBV-converted sublines. , 1981, Journal of immunology.
[85] G. Klein,et al. The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV , 1971, International journal of cancer.
[86] V. Diehl,et al. Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis. , 1968, Proceedings of the National Academy of Sciences of the United States of America.
[87] D. Fearon,et al. Identification of a 145 , 000 Mr membrane protein as the C 3 d receptor ( CR 2 ) of human , 2022 .